Titan Pharmaceuticals, Inc. (NASDAQ:TTNP – Get Free Report)’s share price crossed below its two hundred day moving average during trading on Monday . The stock has a two hundred day moving average of $7.17 and traded as low as $7.01. Titan Pharmaceuticals shares last traded at $7.01, with a volume of 602 shares trading hands.
Wall Street Analysts Forecast Growth
Separately, StockNews.com began coverage on shares of Titan Pharmaceuticals in a research report on Tuesday. They set a “sell” rating for the company.
Read Our Latest Report on TTNP
Titan Pharmaceuticals Stock Performance
Titan Pharmaceuticals Company Profile
Titan Pharmaceuticals, Inc, a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in the United States, Canada, and the European Union.
See Also
- Five stocks we like better than Titan Pharmaceuticals
- How Can Investors Benefit From After-Hours Trading
- High-Yield Texas Instruments Could Hit New Highs Soon
- Options Trading – Understanding Strike Price
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Titan Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Titan Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.